Follow the Bliss GVS Pharma stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €61.9bn. The latest transaction was reported on 24 August 2026 (Disposal). Among the most active insiders: Life Insurance Corporation of India. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€619,780
5 ops.
Sell Volume
27Σ signal
Buys n/a€619,780 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,293 of 29,063 companies
55.9
score / 100
Value
34
Quality
77
FCF yld1.3%
Earn yld2.0%
EV/EBITDA28.9x
ROE12%
Gross mgn54%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
217,123 shares@ ₹285.80100.0% of flowEquity SharesMarket SaleSEBI:c5e548057f09bd37bff69964fffc13407d6ccdb1
6 of 6 declarations
Acerca de Bliss GVS Pharma
Bliss GVS Pharma es una empresa farmacéutica especializada en la fabricación de productos farmacéuticos genéricos y formulaciones. Cotiza en el mercado XBOM.